Pentagon Eyes Search for Virus-Fighting Protein ‘Cocktails’

Diane Barnes
Add to Briefcase
See more stories about...
Diane Barnes
Oct. 4, 2013, 10:02 a.m.

WASH­ING­TON — The U.S. De­fense De­part­ment is weigh­ing a new search for im­mune-pro­tein “cock­tails” it hopes will pro­tect hu­mans against Ebola and oth­er deadly, weapon-us­able vir­uses.

The Pentagon two weeks ago in­vited sci­ent­ists to sub­mit re­search pro­pos­als for design­ing “mono­clonal an­ti­bod­ies” that could pro­tect against Ebola and Mar­burg, as well as “al­phavir­uses” such as Venezuelan equine en­ceph­al­it­is.

Pentagon plan­ners have been turn­ing to an­ti­bod­ies as a pos­sible tool be­cause “no easy and quick fix” for such agents has emerged from ef­forts to de­vel­op vac­cines or tra­di­tion­al an­ti­vir­al treat­ments, said Gigi Gron­vall, a seni­or as­so­ci­ate with the Cen­ter for Health Se­cur­ity at the Uni­versity of Pitt­s­burgh Med­ic­al Cen­ter.

The early-stage re­search now un­der con­sid­er­a­tion ideally would lead to single-shot treat­ments cap­able of guard­ing troops for months from mul­tiple vir­us types, the De­fense Threat Re­duc­tion Agency said in a Sept. 18 so­li­cit­a­tion. DTRA of­fi­cials wel­comed re­search­ers to pro­pose “‘cock­tails’ that may en­able cross-pro­tec­tion against mul­tiple spe­cies of vir­us.”

The em­phas­is on “cock­tails” makes the latest DTRA pro­pos­al par­tic­u­larly not­able, be­cause sev­er­al stud­ies sug­gest that mixes of sev­er­al an­ti­bod­ies can be par­tic­u­larly ef­fect­ive in fight­ing patho­gens, Gron­vall told Glob­al Se­cur­ity News­wire in a tele­phone in­ter­view. An­ti­bod­ies hit their tar­gets with such spe­cificity that a treat­ment with mul­tiple im­mune pro­teins can help ac­count for slight vari­ations between in­vad­ing mi­crobes.

Mono­clonal an­ti­bod­ies have been in use since the 1980s to treat can­cer and im­mune-linked ail­ments such as rheum­at­oid arth­rit­is, but their use against in­fec­tious patho­gens has lagged, ac­cord­ing to a DTRA-sponsored re­port co-au­thored by Gron­vall on the tech­no­logy’s biode­fense po­ten­tial.

The United States last year li­censed the first in­hal­a­tion an­thrax treat­ment to use the tech­no­logy, which in­volves cre­at­ing massive quant­it­ies of a single im­mune “an­ti­body.” The hu­man body nat­ur­ally gen­er­ates such pro­teins, each of which is de­signed to mark a spe­cif­ic patho­gen or tox­in for elim­in­a­tion by oth­er im­mune-sys­tem com­pon­ents.

One an­ti­body cock­tail grown in mod­i­fied to­bacco plants showed prom­ising po­tency against Ebola in­fec­tions spe­cific­ally, ac­cord­ing to a study pub­lished in Au­gust.

“There have been a lot of changes in the way that mono­clonal an­ti­body tech­no­lo­gies have evolved over the last sev­er­al years, and it makes mono­clonal an­ti­bod­ies a very nice piece of their ap­proach to med­ic­al coun­ter­meas­ures,”  Gron­vall said.

The latest DTRA Broad Agency An­nounce­ment seeks pro­pos­als for stud­ies no longer than one year, with a cost no great­er than $500 mil­lion. The fil­ing dead­line is Oct. 16.

What We're Following See More »
STARTS LEGAL FUND FOR WH STAFF
Trump to Begin Covering His Own Legal Bills
1 days ago
THE DETAILS
DISCUSSED THE MATTER FOR A NEW BOOK
Steele Says Follow the Money
1 days ago
STAFF PICKS

"Christopher Steele, the former British intelligence officer who wrote the explosive dossier alleging ties between Donald Trump and Russia," says in a new book by The Guardian's Luke Harding that "Trump's land and hotel deals with Russians needed to be examined. ... Steele did not go into further detail, Harding said, but seemed to be referring to a 2008 home sale to the Russian oligarch Dmitry Rybolovlev. Richard Dearlove, who headed the UK foreign-intelligence unit MI6 between 1999 and 2004, said in April that Trump borrowed money from Russia for his business during the 2008 financial crisis."

Source:
BRITISH PUBLICIST CONNECTED TO TRUMP TOWER MEETING
Goldstone Ready to Meet with Mueller’s Team
1 days ago
THE LATEST

"The British publicist who helped set up the fateful meeting between Donald Trump Jr. and a group of Russians at Trump Tower in June 2016 is ready to meet with Special Prosecutor Robert Mueller's office, according to several people familiar with the matter. Rob Goldstone has been living in Bangkok, Thailand, but has been communicating with Mueller's office through his lawyer, said a source close to Goldstone."

Source:
SPEAKING ON RUSSIAN STATE TV
Kislyak Says Trump Campaign Contacts Too Numerous to List
1 days ago
THE LATEST

"Russian Ambassador Sergey Kislyak said on Wednesday that it would take him more than 20 minutes to name all of the Trump officials he's met with or spoken to on the phone. ... Kislyak made the remarks in a sprawling interview with Russia-1, a popular state-owned Russian television channel."

Source:
“BLOWING A SURE THING”
Sabato Moves Alabama to “Lean Democrat”
2 days ago
WHY WE CARE
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login